Does TACROLIMUS Cause Focal segmental glomerulosclerosis? 339 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 339 reports of Focal segmental glomerulosclerosis have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.4% of all adverse event reports for TACROLIMUS.
339
Reports of Focal segmental glomerulosclerosis with TACROLIMUS
0.4%
of all TACROLIMUS reports
8
Deaths
118
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From TACROLIMUS?
Of the 339 reports, 8 (2.4%) resulted in death, 118 (34.8%) required hospitalization, and 9 (2.7%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 339 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Focal segmental glomerulosclerosis?
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
MYCOPHENOLIC ACID (55)
Which TACROLIMUS Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB